Fig. 1
From: KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma
Mutations detected in LB and OS. A- Oncoplot for mutations detected in metastatic disease at LB. B- Oncoplot for mutations detected in localized disease at LB. C- Difference in median VAF of mutations detected in LB between localized disease and metastatic disease. D-Rates of actionable mutations detected in LB by OncoKB therapeutic levels